{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:24:49Z","timestamp":1785151489409,"version":"3.55.0"},"reference-count":191,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R01HL159865"],"award-info":[{"award-number":["R01HL159865"]}]},{"name":"NIH","award":["23POST1022457"],"award-info":[{"award-number":["23POST1022457"]}]},{"DOI":"10.13039\/100000968","name":"AHA","doi-asserted-by":"publisher","award":["R01HL159865"],"award-info":[{"award-number":["R01HL159865"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"AHA","doi-asserted-by":"publisher","award":["23POST1022457"],"award-info":[{"award-number":["23POST1022457"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Mortality from myocardial infarction (MI) has declined over recent decades, which could be attributed in large part to improved treatment methods. Early reperfusion is the cornerstone of current MI treatment. However, reoxygenation via restored blood flow induces further damage to the myocardium, leading to ischemia-reperfusion injury (IRI). While experimental studies overwhelmingly demonstrate that females experience greater functional recovery from MI and decreased severity in the underlying pathophysiological mechanisms, the outcomes of MI with subsequent reperfusion therapy, which is the clinical correlate of myocardial IRI, are generally poorer for women compared with men. Distressingly, women are also reported to benefit less from current guideline-based therapies compared with men. These seemingly contradicting outcomes between experimental and clinical studies show a need for further investigation of sex-based differences in disease pathophysiology, treatment response, and a sex-specific approach in the development of novel therapeutic methods against myocardial IRI. In this literature review, we summarize the current knowledge on sex differences in the underlying pathophysiological mechanisms of myocardial IRI, including the roles of sex hormones and sex chromosomes. Furthermore, we address sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics of current drugs prescribed to limit myocardial IRI. Lastly, we highlight ongoing clinical trials assessing novel pharmacological treatments against myocardial IRI and sex differences that may underlie the efficacy of these new therapeutic approaches.<\/jats:p>","DOI":"10.3390\/cells12162077","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:08:09Z","timestamp":1692180489000},"page":"2077","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives"],"prefix":"10.3390","volume":"12","author":[{"given":"Lejla","family":"Medzikovic","sequence":"first","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Azem","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6419-5162","authenticated-orcid":false,"given":"Wasila","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmis","family":"Rejali","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leana","family":"Esdin","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadie","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ateyeh","family":"Dehghanitafti","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Aryan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-9976","authenticated-orcid":false,"given":"Mansoureh","family":"Eghbali","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology & Perioperative Medicine, Division of Molecular Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, CHS BH-550 CHS, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: A systematic analysis for the Global Burden of Disease Study 2017; GBD 2017 Causes of Death Collaborators","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics\u20142022 Update: A Report From the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCULATIONAHA.114.013797","article-title":"How Does Cardiovascular Disease First Present in Women and Men?","volume":"132","author":"George","year":"2015","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jamainternmed.2016.5451","article-title":"Lifelong Gender Gap in Risk of Incident Myocardial Infarction: The Troms\u00f8 Study","volume":"176","author":"Albrektsen","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"g5992","DOI":"10.1136\/bmj.g5992","article-title":"Sex differences in lifetime risk and first manifestation of cardiovascular disease: Prospective population based cohort study","volume":"349","author":"Leening","year":"2014","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: A neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamainternmed.2018.0514","article-title":"Sex Differences in Outcomes After STEMI","volume":"178","author":"Cenko","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jamainternmed.2014.4762","article-title":"Sex Differences in Short-term and Long-term All-Cause Mortality Among Patients With ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Intervention","volume":"174","author":"Pancholy","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.122.062049","article-title":"Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation","volume":"147","author":"Coughlan","year":"2023","journal-title":"Circulation"},{"key":"ref_10","first-page":"1","article-title":"Sex-related impacts on clinical outcomes after percutaneous coronary intervention","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.015293","article-title":"Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women","volume":"132","author":"Wilmot","year":"2015","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ahj.2013.11.001","article-title":"Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: Evidence from the NCDR\u00ae","volume":"167","author":"Lichtman","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e004319","DOI":"10.1161\/JAHA.116.004319","article-title":"Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization","volume":"6","author":"Udell","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Baehr, A., Klymiuk, N., and Kupatt, C. (2019). Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194749"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2174\/1389450117666160401120308","article-title":"Progress in Therapies for Myocardial Ischemia Reperfusion Injury","volume":"18","author":"Chi","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/eurheartj\/ehz898","article-title":"Sex and gender in cardiovascular medicine: Presentation and outcomes of acute coronary syndrome","volume":"41","author":"Haider","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","article-title":"Myocardial Infarction\u2014From Atherosclerosis to Thrombosis: Uncovering New Diagnostic and Therapeutic Approaches","volume":"39","author":"Palasubramaniam","year":"2019","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kuznetsov, A.V., Javadov, S., Margreiter, R., Grimm, M., Hagenbuchner, J., and Ausserlechner, M.J. (2019). The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury. Antioxidants, 8.","DOI":"10.3390\/antiox8100454"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1111\/jcmm.15180","article-title":"Cardiac metabolism as a driver and therapeutic target of myocardial infarction","volume":"24","author":"Zuurbier","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s11064-019-02769-6","article-title":"Sex Differences in Ischemia\/Reperfusion Injury: The Role of Mitochondrial Permeability Transition","volume":"44","author":"Fels","year":"2019","journal-title":"Neurochem. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e015672","DOI":"10.1161\/JAHA.119.015672","article-title":"Molecular and Cellular Differences in Cardiac Repair of Male and Female Mice","volume":"9","author":"Pullen","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1139\/cjpp-2019-0060","article-title":"Developmental and sex differences in cardiac tolerance to ischemia\u2013reperfusion injury: The role of mitochondria","volume":"97","author":"Ostadal","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3181\/0812-MR-362","article-title":"Gender Differences in Cardiac Ischemic Injury and Protection\u2014Experimental Aspects","volume":"234","author":"Ostadal","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-012-0288-y","article-title":"Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and\/or taken into account: Results of a comprehensive analysis of determinants of infarct size in 1074 mice","volume":"107","author":"Guo","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"ref_27","first-page":"1125","article-title":"Gender Differences in Cardioprotection against Ischemia\/Reperfusion Injury in Adult Rat Hearts: Focus on Akt and Protein Kinase C Signaling","volume":"315","author":"Bae","year":"2005","journal-title":"Experiment"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"H2644","DOI":"10.1152\/ajpheart.01291.2005","article-title":"Sex differences in myocardial infarct size are abolished by sarcolemmal KATPchannel blockade in rat","volume":"290","author":"Johnson","year":"2006","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1210\/en.2013-1755","article-title":"Role of Androgens in Sex Differences in Cardiac Damage During Myocardial Infarction","volume":"155","author":"Le","year":"2014","journal-title":"Endocrinology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"H1510","DOI":"10.1152\/ajpheart.01021.2009","article-title":"Sex-related resistance to myocardial ischemia-reperfusion injury is associated with high constitutive ARC expression","volume":"298","author":"Bouma","year":"2010","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cardiores.2007.02.001","article-title":"Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage","volume":"74","author":"Colom","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/CIRCRESAHA.109.213645","article-title":"Sex Differences in the Phosphorylation of Mitochondrial Proteins Result in Reduced Production of Reactive Oxygen Species and Cardioprotection in Females","volume":"106","author":"Lagranha","year":"2010","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lfs.2013.06.019","article-title":"Apoptosis and autophagy contribute to gender difference in cardiac ischemia\u2013reperfusion induced injury in rats","volume":"93","author":"Chen","year":"2013","journal-title":"Life Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"H221","DOI":"10.1152\/ajpheart.00784.2004","article-title":"Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion","volume":"288","author":"Wang","year":"2005","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12265-016-9675-3","article-title":"Estrogenic Impact on Cardiac Ischemic\/Reperfusion Injury","volume":"9","author":"Sivasinprasasn","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"H2766","DOI":"10.1152\/ajpheart.2000.279.6.H2766","article-title":"Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats","volume":"279","author":"Zhai","year":"2000","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3389\/fendo.2019.00733","article-title":"Non-genomic Effects of Estrogen on Cell Homeostasis and Remodeling With Special Focus on Cardiac Ischemia\/Reperfusion Injury","volume":"10","author":"Puglisi","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-022-00842-2","article-title":"Estrogen inhibits endoplasmic reticulum stress and ameliorates myocardial ischemia\/reperfusion injury in rats by upregulating SERCA2a","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2011.06.030","article-title":"Inhibition of mitochondrial Na+-dependent Ca2+ efflux by 17\u03b2-estradiol in the rat hippocampus","volume":"192","author":"Horvat","year":"2011","journal-title":"Neuroscience"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.surg.2010.03.011","article-title":"Signaling via GPR30 protects the myocardium from ischemia\/reperfusion injury","volume":"148","author":"Weil","year":"2010","journal-title":"Surgery"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"H16","DOI":"10.1152\/ajpheart.00588.2009","article-title":"A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury","volume":"298","author":"Bopassa","year":"2010","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.bbadis.2016.10.003","article-title":"Cardiomyocyte-specific deletion of the G protein-coupled estrogen receptor (GPER) leads to left ventricular dysfunction and adverse remodeling: A sex-specific gene profiling analysis","volume":"1863","author":"Wang","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Luo, T., Liu, H., and Kim, J.K. (2016). Estrogen Protects the Female Heart from Ischemia\/Reperfusion Injury through Manganese Superoxide Dismutase Phosphorylation by Mitochondrial p38\u03b2 at Threonine 79 and Serine 106. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167761"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Romero-Becerra, R., Santamans, A.M., Folgueira, C., and Sabio, G. (2020). p38 MAPK Pathway in the Heart: New Insights in Health and Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197412"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cardiores.2005.11.031","article-title":"Estrogen improves cardiac recovery after ischemia\/reperfusion by decreasing tumor necrosis factor-\u03b1","volume":"69","author":"Xu","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2005.06.019","article-title":"17-\u03b2-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia","volume":"40","author":"Wang","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41591-019-0643-8","article-title":"Sex differences in cardiometabolic disorders","volume":"25","author":"Gerdts","year":"2019","journal-title":"Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.106.084798","article-title":"Both Estrogen Receptor Subtypes, \u03b1 and \u03b2, Attenuate Cardiovascular Remodeling in Aldosterone Salt\u2013Treated Rats","volume":"50","author":"Hu","year":"2007","journal-title":"Hypertension"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e008758","DOI":"10.1161\/CIRCHEARTFAILURE.121.008758","article-title":"Estrogen Protects Cardiac Function and Energy Metabolism in Dilated Cardiomyopathy Induced by Loss of Cardiac IRS1 and IRS2","volume":"15","author":"Yan","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1210\/en.2007-0620","article-title":"Estrogen-Enhanced Gene Expression of Lipoprotein Lipase in Heart Is Antagonized by Progesterone","volume":"149","author":"Liu","year":"2007","journal-title":"Endocrinology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2011.09.054","article-title":"Transcriptome Characterization of Estrogen-Treated Human Myocardium Identifies Myosin Regulatory Light Chain Interacting Protein as a Sex-Specific Element Influencing Contractile Function","volume":"59","author":"Kararigas","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/FJC.0000000000001013","article-title":"Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein\u2013Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches","volume":"77","author":"Pascale","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","article-title":"Alox15\/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis","volume":"147","author":"Cai","year":"2023","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/physiol.00057.2014","article-title":"The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic Syndrome","volume":"31","author":"Brooks","year":"2016","journal-title":"Physiology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"H1461","DOI":"10.1152\/ajpheart.00555.2019","article-title":"Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease","volume":"318","author":"Konhilas","year":"2020","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/GME.0b013e3182960cf8","article-title":"Critical window hypothesis of hormone therapy and cognition","volume":"20","author":"Maki","year":"2013","journal-title":"Menopause"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jama.2022.18324","article-title":"Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"328","author":"Gartlehner","year":"2022","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1074248415587977","article-title":"Roles of Testosterone Replacement in Cardiac Ischemia\u2013Reperfusion Injury","volume":"21","author":"Pongkan","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"H2043","DOI":"10.1152\/ajpheart.01121.2005","article-title":"Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function","volume":"290","author":"Cavasin","year":"2006","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Pongkan, W., Chattipakorn, S.C., and Chattipakorn, N. (2015). Chronic Testosterone Replacement Exerts Cardioprotection against Cardiac Ischemia-Reperfusion Injury by Attenuating Mitochondrial Dysfunction in Testosterone-Deprived Rats. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122503"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105335","DOI":"10.1016\/j.jsbmb.2019.03.012","article-title":"Paradoxical effect of testosterone supplementation therapy on cardiac ischemia\/reperfusion injury in aged rats","volume":"191","author":"Seara","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1200\/JCO.2014.60.2649","article-title":"Cardiovascular Disease Associated With Androgen-Deprivation Therapy: Time to Give It Due Respect","volume":"33","author":"Basaria","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e020562","DOI":"10.1161\/JAHA.120.020562","article-title":"Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities","volume":"10","author":"Shores","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_66","first-page":"e17475","article-title":"Testosterone Replacement Therapy in Hypogonadal Men and Myocardial Infarction Risk: Systematic Review & Meta-Analysis","volume":"13","author":"Lee","year":"2021","journal-title":"Cureus"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5114\/pm.2020.101941","article-title":"Changes of androgens levels in menopausal women","volume":"19","author":"Brzozowska","year":"2020","journal-title":"Menopausal Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"260","DOI":"10.31083\/j.ceog4912260","article-title":"Association between Testosterone\/Estradiol Ratio and Risk of Cardiometabolic Diseases in Women at Menopause Transition Age","volume":"49","author":"Awadji","year":"2022","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.jacc.2018.01.083","article-title":"Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women","volume":"71","author":"Zhao","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.122.320259","article-title":"Illuminating the Mechanisms Underlying Sex Differences in Cardiovascular Disease","volume":"130","author":"Reue","year":"2022","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cvr\/cvu064","article-title":"The number of X chromosomes influences protection from cardiac ischaemia\/reperfusion injury in mice: One X is better than two","volume":"102","author":"Li","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fcell.2019.00241","article-title":"Escape From X-Chromosome Inactivation: An Evolutionary Perspective","volume":"7","author":"Posynick","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12974-021-02120-3","article-title":"X chromosome escapee genes are involved in ischemic sexual dimorphism through epigenetic modification of inflammatory signals","volume":"18","author":"Qi","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.121.054108","article-title":"Genes That Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts","volume":"145","author":"Aguado","year":"2022","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e021799","DOI":"10.1161\/JAHA.121.021799","article-title":"Pharmacological Treatment Following Myocardial Infarction: How Large Is the Gap Between Guideline Recommendations and Routine Clinical Care?","volume":"10","author":"Schupp","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"113804","DOI":"10.1016\/j.addr.2021.05.014","article-title":"Let\u2019s talk about sex: Differences in drug therapy in males and females","volume":"175","author":"Madla","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol. Sex Differ."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Fenech, A.G., and Magri, V.P. (2020). Gender Differences in Drug Therapy. Am. J. Ther., 547\u2013570.","DOI":"10.1007\/978-3-319-68864-0_69"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042","article-title":"Gender differences in the effects of cardiovascular drugs","volume":"3","author":"Tamargo","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fphar.2020.00564","article-title":"Gender Differences in Cardiovascular Pharmacotherapy\u2014The Example of Hypertension: A Mini Review","volume":"11","author":"Kalibala","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/0091270008323754","article-title":"Gender Has a Small but Statistically Significant Effect on Clearance of CYP3A Substrate Drugs","volume":"48","author":"Greenblatt","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear Pregnane X Receptor and Constitutive Androstane Receptor Regulate Overlapping but Distinct Sets of Genes Involved in Xenobiotic Detoxification","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 Is Regulated by Estradiol via Estrogen Receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein Inhibition for Optimal Drug Delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-Glycoprotein Transport System and Cardiovascular Drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/138920009788498996","article-title":"Gender Differences in P-Glycoprotein Expression and Function: Effects on Drug Disposition and Outcome","volume":"10","author":"Bebawy","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jacc.2015.08.865","article-title":"Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States","volume":"66","author":"Khera","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.117.031650","article-title":"Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction","volume":"137","author":"Lichtman","year":"2018","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjcard.2015.10.029","article-title":"Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)","volume":"117","author":"Ng","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/clc.22310","article-title":"Gender Differences in Coronary Artery Diameter Are Not Related to Body Habitus or Left Ventricular Mass","volume":"37","author":"Hiteshi","year":"2014","journal-title":"Clin. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"ref_92","first-page":"e362","article-title":"2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Kushner","year":"2013","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.CIR.93.5.870","article-title":"Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial Infarction: Results From the GUSTO-I Trial","volume":"93","author":"Granger","year":"1996","journal-title":"Circulation"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/2048872618803760","article-title":"Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial","volume":"8","author":"Venetsanos","year":"2018","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e012161","DOI":"10.1161\/JAHA.119.012161","article-title":"Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention","volume":"8","author":"Stehli","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heartjnl-2018-313959","article-title":"Sex differences in quality indicator attainment for myocardial infarction: A nationwide cohort study","volume":"105","author":"Wilkinson","year":"2018","journal-title":"Heart"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e007123","DOI":"10.1161\/JAHA.117.007123","article-title":"Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry","volume":"6","author":"Alabas","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.108.789800","article-title":"Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction","volume":"118","author":"Jneid","year":"2008","journal-title":"Circulation"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e014742","DOI":"10.1161\/JAHA.119.014742","article-title":"Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis","volume":"9","author":"Zhao","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.121.319894","article-title":"Sex Differences in Cardiac Rehabilitation Outcomes","volume":"130","author":"Smith","year":"2022","journal-title":"Circ. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/HCR.0000000000000629","article-title":"Underutilization of Cardiac Rehabilitation in Women Barriers and Solutions","volume":"41","author":"Khadanga","year":"2021","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1590\/S0100-879X2002000900008","article-title":"Myocardial antioxidant and oxidative stress changes due to sex hormones","volume":"35","author":"Barp","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/hq0302.104515","article-title":"Greater Oxidative Stress in Healthy Young Men Compared With Premenopausal Women","volume":"22","author":"Ide","year":"2002","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_104","first-page":"385","article-title":"Evaluation of Gender-Related Differences in Various Oxidative Stress Enzymes in Mice","volume":"54","author":"Chen","year":"2012","journal-title":"Chin. J. Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.2174\/138161211798764942","article-title":"Females Live Longer than Males: Role of Oxidative Stress","volume":"17","author":"Vina","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Shao, Q., Casin, K.M., Mackowski, N., Murphy, E., Steenbergen, C., and Kohr, M.J. (2017). Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177315"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"H505","DOI":"10.1152\/ajpheart.00681.2015","article-title":"Characterization of the sex-dependent myocardial S-nitrosothiol proteome","volume":"310","author":"Shao","year":"2016","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.33549\/physiolres.933412","article-title":"Changes in Activities of Circulating MMP-2 and MMP-9 in Patients Suffering From Heart Failure in Relation to Gender, Hypertension and Treatment: A Cross-Sectional Study","volume":"65","author":"Giannakos","year":"2016","journal-title":"Physiol. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"R683","DOI":"10.1152\/ajpregu.00162.2010","article-title":"Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females","volume":"299","author":"Voloshenyuk","year":"2010","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yjmcc.2006.04.019","article-title":"17\u03b2-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts","volume":"41","author":"Stewart","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cvr\/cvp350","article-title":"17\u03b2-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts","volume":"85","author":"Mahmoodzadeh","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/JIR.S48422","article-title":"Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts","volume":"6","author":"Janicki","year":"2013","journal-title":"J. Inflamm. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e14088","DOI":"10.14814\/phy2.14088","article-title":"Testosterone deficiency reduces cardiac hypertrophy in a rat model of severe volume overload","volume":"7","author":"Beaumont","year":"2019","journal-title":"Physiol. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2011-09-380949","article-title":"The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL","volume":"119","author":"Murawski","year":"2012","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3324\/haematol.2011.059246","article-title":"Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response","volume":"97","author":"Fridrik","year":"2012","journal-title":"Haematologica"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"958136","DOI":"10.3389\/fphar.2022.958136","article-title":"Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome","volume":"13","author":"Perna","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e2023216118","DOI":"10.1073\/pnas.2023216118","article-title":"Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis","volume":"118","author":"Huang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Farkouh, A., Baumg\u00e4rtel, C., Gottardi, R., Hemetsberger, M., Czejka, M., and Kautzky-Willer, A. (2021). Sex-Related Differences in Drugs with Anti-Inflammatory Properties. J. Clin. Med., 10.","DOI":"10.3390\/jcm10071441"},{"key":"ref_119","first-page":"327","article-title":"Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression","volume":"370","author":"Ayyar","year":"2019","journal-title":"Experiment"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"ra74","DOI":"10.1126\/scisignal.2001077","article-title":"Sexually Dimorphic Actions of Glucocorticoids Provide a Link to Inflammatory Diseases with Gender Differences in Prevalence","volume":"3","author":"Duma","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00134-020-06325-7","article-title":"Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock","volume":"47","author":"Thompson","year":"2021","journal-title":"Intensiv. Care Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ccd.25630","article-title":"Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS-AMI trial","volume":"85","author":"Yu","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.106.620815","article-title":"Sex Differences in Major Bleeding With Glycoprotein IIb\/IIIa Inhibitors","volume":"114","author":"Alexander","year":"2006","journal-title":"Circulation"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.atherosclerosis.2014.10.095","article-title":"Sex differences of leukocyte\u2013platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis","volume":"237","author":"Gremmel","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Ranucci, M., Aloisio, T., Dedda, U.D., Menicanti, L., De Vincentiis, C., and Baryshnikova, E. (2019). Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225771"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.ATV.0000110445.95304.91","article-title":"Platelets of Female Mice Are Intrinsically More Sensitive to Agonists Than Are Platelets of Males","volume":"24","author":"Leng","year":"2004","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/rth2.12344","article-title":"Sex differences in flow cytometry\u2013based platelet reactivity in stable outpatients suspected of myocardial ischemia","volume":"4","author":"Waissi","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/09537104.2018.1466387","article-title":"Effects of age, gender and menstrual cycle on platelet function assessed by impedance aggregometry","volume":"30","author":"Berlin","year":"2018","journal-title":"Platelets"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.25122\/jml-2019-0005","article-title":"Modulation of Platelet Functions Assessment during Menstruation and Ovulatory Phases","volume":"12","author":"Alzahrani","year":"2019","journal-title":"J. Med. Life"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Dupuis, M., Severin, S., Esclassan, N., Arnal, J.-F., Payrastre, B., and Val\u00e9ra, M.-C. (2019). Effects of Estrogens on Platelets and Megakaryocytes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123111"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/253355a0","article-title":"Sex and age differences in human platelet aggregation","volume":"253","author":"Johnson","year":"1975","journal-title":"Nature"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ro\u015fca, A.E., Vl\u0103d\u0103reanu, A.-M., Mititelu, A., Popescu, B.O., Badiu, C., C\u0103runtu, C., Voiculescu, S.E., Onis\u00e2i, M., Gologan, \u015e., and Mirica, R. (2021). Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10010147"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1161\/ATVBAHA.122.318725","article-title":"Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial","volume":"43","author":"Lee","year":"2023","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.jacc.2013.02.030","article-title":"Patterns of Use and Comparative Effectiveness of Bleeding Avoidance Strategies in Men and Women Following Percutaneous Coronary Interventions: An Observational Study from the National Cardiovascular Data Registry\u00ae","volume":"61","author":"Daugherty","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamacardio.2021.1720","article-title":"Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial","volume":"6","author":"Vogel","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijcard.2022.10.166","article-title":"Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trial","volume":"370","author":"Sandner","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2017.01.028","article-title":"Potent P2Y 12 Inhibitors in Men Versus Women","volume":"69","author":"Lau","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/01.STR.0000150515.15576.29","article-title":"Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke","volume":"36","author":"Kent","year":"2005","journal-title":"Stroke"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40263-023-00997-7","article-title":"Sex Differences in Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Preadmission Use of Antiplatelets","volume":"37","author":"Noseda","year":"2023","journal-title":"CNS Drugs"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jacc.2005.02.025","article-title":"Gender Differences in Endothelial Tissue-Type Plasminogen Activator Release in Middle-Aged Adults","volume":"45","author":"Stauffer","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0037-1616086","article-title":"Impairment of the Plasmin Activation System in Primary Pulmonary Hypertension: Evidence for Gender Differences","volume":"86","author":"Graf","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"711604","DOI":"10.3389\/fncel.2021.711604","article-title":"Sex Differences in Hemostatic Factors in Patients With Ischemic Stroke and the Relation With Migraine\u2014A Systematic Review","volume":"15","author":"Ali","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6118\/jmm.19005","article-title":"Effects of 17\u03b2-Estradiol on the Plasminogen Activator System in Vascular Smooth Muscle Cells Treated with Lysophophatidylcholine","volume":"26","author":"Yoon","year":"2020","journal-title":"J. Menopausal Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-022-00474-8","article-title":"Chromosomal and gonadal sex drive sex differences in lipids and hepatic gene expression in response to hypercholesterolemia and statin treatment","volume":"13","author":"Wiese","year":"2022","journal-title":"Biol. Sex Differ."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"953845","DOI":"10.3389\/fphar.2022.953845","article-title":"Sex difference in circulating PCSK9 and its clinical implications","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fendo.2019.00930","article-title":"17\u03b2-Estradiol Inhibits PCSK9-Mediated LDLR Degradation Through GPER\/PLC Activation in HepG2 Cells","volume":"10","author":"Fu","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/febs.13309","article-title":"\u03b2-Estradiol results in a proprotein convertase subtilisin\/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells","volume":"282","author":"Starr","year":"2015","journal-title":"FEBS J."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Galema-Boers, A.M., Mulder, J.W., Steward, K., and van Lennep, J.E.R. (2023). Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry. Atherosclerosis.","DOI":"10.1016\/j.atherosclerosis.2023.03.013"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/FJC.0000000000001205","article-title":"Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry","volume":"79","author":"Cordero","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacl.2022.12.002","article-title":"Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience","volume":"17","author":"Paquette","year":"2022","journal-title":"J. Clin. Lipidol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2021.02.024","article-title":"Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care","volume":"324","author":"Rachamin","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"C1174","DOI":"10.1152\/ajpcell.00450.2011","article-title":"Expression of Na+-d-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences","volume":"302","author":"Vrhovac","year":"2012","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_153","first-page":"856","article-title":"Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues","volume":"69","author":"Yoshida","year":"2014","journal-title":"Die Pharm.\u2014Int. J. Pharm. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.ahjo.2023.100261","article-title":"Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis","volume":"26","author":"Rivera","year":"2023","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2021.11.016","article-title":"A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI","volume":"347","author":"Adlam","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.RES.47.6.807","article-title":"The role of adenosine in the regulation of coronary blood flow","volume":"47","author":"Berne","year":"1980","journal-title":"Circ. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.CIR.97.6.521","article-title":"Adenosine Inhibits Lipopolysaccharide-Induced Secretion of Tumor Necrosis Factor-\u03b1 in the Failing Human Heart","volume":"97","author":"Wagner","year":"1998","journal-title":"Circulation"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.bjp.0703893","article-title":"Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A2Areceptor agonists","volume":"132","author":"Sullivan","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"H1456","DOI":"10.1152\/ajpheart.1996.271.4.H1456","article-title":"Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium","volume":"271","author":"Sato","year":"1996","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3389\/fphar.2020.00872","article-title":"Targeting Calcium Homeostasis in Myocardial Ischemia\/Reperfusion Injury: An Overview of Regulatory Mechanisms and Therapeutic Reagents","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jcin.2015.08.033","article-title":"Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration","volume":"8","author":"Yetgin","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.pmbts.2017.02.001","article-title":"Matrix Metalloproteinases in Myocardial Infarction and Heart Failure","volume":"147","author":"Meschiari","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00395-014-0424-y","article-title":"Targeting MMP-2 to treat ischemic heart injury","volume":"109","author":"Hughes","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurheartj\/ehi007","article-title":"Ischaemia\u2013reperfusion injury activates matrix metalloproteinases in the human heart","volume":"26","author":"Lalu","year":"2004","journal-title":"Eur. Heart J."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Trentini, A., Manfrinato, M.C., Castellazzi, M., and Bellini, T. (2022). Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081196"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.lfs.2004.04.024","article-title":"Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice","volume":"75","author":"Cavasin","year":"2004","journal-title":"Life Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2015.06.024","article-title":"Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial","volume":"197","author":"Cerisano","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1084460","DOI":"10.3389\/fimmu.2022.1084460","article-title":"The role of major immune cells in myocardial infarction","volume":"13","author":"Feng","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nm.3284","article-title":"B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction","volume":"19","author":"Zouggari","year":"2013","journal-title":"Nat. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/cvr\/cvab113","article-title":"Rituximab in patients with acute ST-elevation myocardial infarction: An experimental medicine safety study","volume":"118","author":"Zhao","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","article-title":"A General Introduction to Glucocorticoid Biology","volume":"10","author":"Timmermans","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","article-title":"Non-genomic Effects of Glucocorticoids: An Updated View","volume":"40","author":"Panettieri","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/bph.14155","article-title":"Anti-inflammatory therapies in myocardial infarction: Failures, hopes and challenges","volume":"175","author":"Huang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI20986","article-title":"Central role of the P2Y12 receptor in platelet activation","volume":"113","author":"Dorsam","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: Signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.99.11.1411","article-title":"Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking: A mechanism for arterial thrombosis and myocardial infarction","volume":"99","author":"Newby","year":"1999","journal-title":"Circulation"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1161\/CIRCULATIONAHA.108.793745","article-title":"Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction","volume":"119","author":"Huynh","year":"2009","journal-title":"Circulation"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0037-1613959","article-title":"Increased Fibrinolytic Activity during Use of Oral Contraceptives Is Counteracted by an Enhanced Factor XI-independent down Regulation of Fibrinolysis","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb. Haemost."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Morofuji, Y., Nakagawa, S., Ujifuku, K., Fujimoto, T., Otsuka, K., Niwa, M., and Tsutsumi, K. (2022). Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharmaceuticals, 15.","DOI":"10.3390\/ph15020151"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ. Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"107424842211001","DOI":"10.1177\/10742484221100107","article-title":"A Comprehensive Review of PCSK9 Inhibitors","volume":"27","author":"Coppinger","year":"2022","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/ATVBAHA.114.304326","article-title":"G-Protein Estrogen Receptor as a Regulator of Low-Density Lipoprotein Cholesterol Metabolism: Cellular and population genetic studies","volume":"35","author":"Hussain","year":"2015","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dsx.2020.02.012","article-title":"Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: A systematic review and meta-analysis of cardio-vascular outcome trials","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"100692","DOI":"10.1016\/j.lanwpc.2023.100692","article-title":"Sex differences in risk of cardiovascular events and mortality with sodium glucose co-transporter-2 inhibitors versus glucagon-like peptide 1 receptor agonists in Australians with type 2 diabetes: A population-based cohort study","volume":"33","author":"Sharma","year":"2023","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e012940","DOI":"10.1161\/JAHA.119.012940","article-title":"Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus","volume":"9","author":"Raparelli","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"bvac191","DOI":"10.1210\/jendso\/bvac191","article-title":"Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women","volume":"7","author":"Pruett","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.122.062832","article-title":"Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER","volume":"147","author":"Wang","year":"2023","journal-title":"Circulation"},{"key":"ref_190","first-page":"263","article-title":"Author response for \u201cEffects of SGLT2 inhibitors in type 2 diabetes, comparing women to men\u201d","volume":"22","author":"Zhou","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/16\/2077\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:34:44Z","timestamp":1760128484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/16\/2077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":191,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["cells12162077"],"URL":"https:\/\/doi.org\/10.3390\/cells12162077","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}